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The cutaneous lymphocyte-associated antigen recognized by 
the monoclonal antibody HECA-452 has been thought to 
playa major role in the homing of memory T-cell subsets to 
the skin by virtue of its ability to bind to E-selectin of dermal 
microvascular endothelial cells. Considering that the hom-
ing of different leukocyte populations to the skin may in-
volve similar mechanisms, we studied the expression of 
HECA-452-reactive molecules on COla+ epidermal Lan-
gerhans cells. Immunofluorescence double-labeling of cryo-
stat sections and epidermal sheets of normal skin revealed 
HECA-452 immunoreactivity on a subpopulation of dermal 
and epidermal COla+ cells, whereas upon flow-cytometric 
analysis of epidermal single cell suspensions virtually all 
CD1a+ cells bound HECA-452 antibodies. We observed a 
marked upregulation of HECA-452-antigen expression on 
CD 1a+ epidermal cells and a pronounced increase in the 
number ofHECA-452+ /COla+ dermal cells in lesional skin 
E pidermal Langerhans cells (LC) are major histocompati-bility complex class I/class II-bearing dendritic leuko-cytes with potent antigen-specific T -cell- stimulating properties [1,2] . Whereas LC were previously regarded as a rather sessile cell population, it is now clear that the 
fairly constant numbers of anti-CD la-reactive human LC result 
from a delicately balanced interplay of three factors: a) immigration, 
b) mitosis, and c) emigration. Although the occurrence of these 
truee events has been amply documented [3], the mechanisms un-
derlying these phenomena are only partly understood. In the very 
recent past, we have gained insight into the factors stimulating 
mitotic activity in putative LC precursors [4] as well as those trig-
gering LC emigration§ [5]; in contrast, the factors responsible for 
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from inflammatory and neoplastic lymphocytic skin diseases, 
compared to normal skin. The molecule detected by the 
HECA-452 antibody on Langerhans cells is neuraminidase 
sensitive and contains a C015 (LewisX) carbohydrate back-
bone. Because Langerhans cells react with the sialyl-
Lewisx-specific antibody CSLEX1, it is very likely that the 
HECA-452-reactive structure is or contains sialyl-Lewisx. 
Our data are compatible with the view that i) resident epi-
dermal Langerhans cells upregulate HECA-452 - antigen 
expression due to the cytokine profile generated in the dis-
ease process or ii) that Langerhans cell precursors express 
HECA-452-antigens and show an enhanced immigration 
into lesional skin. The characterization ofHECA-452+ cells 
in peripheral blood may not only clarify this issue but may 
also help to identify the still elusive Langerhans cell-precur-
sor. Key words: sLeX, CD15. ] Invest DermatoI102:773 -7BO, 
1994 
the immigration of LC/LC precursors into the skin have remained 
enigmatic. 
The reason why one assumes that the homing ofLC to the skin/ 
epidermis occurs in a directed rather than random fashion is based 
on the observations i) that intravenously injected LC specifically 
~ome to the skin (6) and ii) that certain T-Iymphocyte subpopula-
tlOns home preferentially to the skin [7,8] . In this respect, particular 
attention has focused on molecules detected by the monoclonal 
antibody (MoAb) HECA-452. This MoAb reacts with more than 
80% ofT cells infiltrating inflamed areas of the skin, but only with a 
low percentage (less than 10%) ofT cells at other sites of intlamma-
tion [8]. The T-cell structure detected by this MoAb has therefore 
been termed "cutaneous lymphocyte-associated antigen" (CLA) 
[9]. Biochemical studies have revealed that MoAb HECA-452 rec-
ognizes the carbohydrate structures i) sialyl-Lewisx (sLeX), the sia-
lylated form of LewisX (LeX; CD15), ii) sLea, an isomeric form of 
sLex, and iii) closely related carbohydrate moieties [10,11]. Various 
studies indicate that these carbohydrates serve as ligands for E-selec-
tin (previously called endothelial leukocyte adhesion molecule-l 
[ELAM-l]) [10 -13]; this vascular adhesion molecule is constitu-
tively expressed at low levels on endothelial cells of the dermal 
microvasculature and its expression is highly upregulated during 
inflammation [14]. These findings, together with other observa-
tions showing i) that E-selectin - transfected L cells bind to isolated 
CLA-antigen (11) and ii) that memory T cells expressing CLA-anti-
gen bind to E-selectin-transfected COS cells [15] , led to the hy-
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Table I. Antibodies and Reagents U sed in this Study 
Antibody/Conjugates Reactivity Isotype Working Dilution Source' 
HECA-452 CLA Rat IgM 5.ug/ml L. Picker [8] 
CSLEXI sLex Mouse IgM 10.ug/ml Becton Dickinson 
Leu-Ml CDl5 Mouse IgM 5.ug/ml Becton Dickinson 
IOT6 COla Mouse IgG2a 500 ng/ml Immunotech 
OKT6-FITC COla Mouse IgGl 1.6.ug/ ml (250 ng/ml') Ortho Diagnostics 
UCHTl CD3 Mouse IgGl l.ug/ml Dako 
HLe-1-FITC CD45 Mouse IgGl 2.5,ug/ml Becton Dickinson 
Thy-1.1 Mouse IgM 1 : 1000 New England Nuclear Thy-1.1 (control) 
Rat IgM (control) Undefined Myeloma rat IgM 5,ug/ml Serotec 
IgG2a (control) Undefined Mouse IgG2a 500 ng/ml Immunotech 
1.6.ug/ ml (250 ng/ml') KLH Mouse IgG1 Becton Dickinson IgG1-FITC (control) 
Sheep-anti-rat biotinylated Rat Ig Polydonal, purified 1 : 200 (1 : 3000') Amersham 
Sheep-anti-mouse F(ab'), biotinylated Mouse Ig Polyclonal, purified 1 : 800 (1: 2000') Amersham 
6.ug/ml Dako Rabbit-anti-mouse F(ab'),-FITC Mouse Ig Polyclonal, purified 
Swine-anti-rabbit-FITC Rabbit Ig Polyclonal, purified 1 :1 00 Dako 
Streptavidin Texas Red (SA-TR) 1 :200 Amersham 
Streptavidin phycoerythrin (SA-PE) 1 : 5 Becton Dickinson 
StreptABComplex 1 : 170 Dako 
, Concentrations and dilutions used for FACS analysis . 
• Immunotech, Marseille, France; Ortho Diagnostic Systems, Raritan, Nj, USA; Becton Dickinson, San Jose, CA, USA; New England Nuclear, Du Pont de Nemours, Bad 
Homburg, Germany; Scrotec, Kidlington, UK; Amersham, Little Chalfont, UK; Dako A/S, Glostrup, Denmark. 
pothesis that the interaction of E-selectin and CLA is crucial for 
T -cell homing to the skin. 
Reasoning that analogous mechanisms could also facilitate the 
homing of other leukocytes to the skin, we searched for the pres-
ence of HECA-452-reactive epitopes on epidermal LC in normal 
and diseased skin. 
MATERIALS AND METHODS 
Specimen Collection, Tissue, and Cell Preparation Four-millimeter 
punch biopsies of normal skin from the upper arm were taken from three 
healthy volunteers with normal-appearing skin and no history of any skin 
disease. Samples of lesional skin were obtained from patients suffering from 
various inflammatory and neoplastic lymphocytic skin diseases (see Table 
II). A small portion of each biopsy was processed for routine histopathology 
and the rest of the specimens were embedded in Tissue-Tec II OCT (Miles 
Laboratory Inc., Elkhart, IN) , frozen in 2-methylbutane (Merck, Darmstadt, 
Germany) cooled with liquid nitrogen, and stored at -80'C. Seven-micro-
meter cryostat sections were cut, mounted on poly-L-Iysine (Sigma Corp., 
St. Louis, MO) or gelatin-coated slides, airdried, fixed in acetone (Fluka, 
Buchs, Switzerland) on ice for 20 min, and stored at -20 'C until use. 
To prepare i) epidermal sheets and ii) epidermal single-cell suspensions for 
flow cytometry, split-thickness skin (0.4 mm) was prepared from normal-
appearing skin obtained from patients undergoing cosmetic surgery or from 
autopsy specimens using an electric dermatome (DePuy Healthcare, Leeds, 
UK). After two to three washes in. ice-cold phos'phate-buff~red saline (PBS) , 
pH 7.4, the skin was exposed to dlspase (2.4 U/ml, Boehnnger Mannhelm, 
Mannheim, Germany) either at 4'C overnight or for 1 hat 37'C. Thereaf-
ter epidermal sheets were removed and either washed twice in PBS and fixed 
for 15 min in ice-cold acetone (Fluka) or incubated for 15 min at 37'C in 
0.1 % (w Iv) trypsin (Sigma)/PBS under mild agitation. The trypsin-treated 
sheets were then vigorously stirred for 45 seconds to release non-coherent 
cells. The resulting cell suspension was filtered through nylon gauze and 
washed in RPMI 1640 medium (Gibco, Paisley, UK) containing 10% fetal 
bovine serum (Gibco) and 0.25 mg/ml DNase I (EC 3.1.21.1, Sigma). 
Immunohistologic Staining Primary and secondary antibodies used in 
this study are listed in Table l. Antibodies were diluted in staining-buffer 
containing 5% (w Iv) milk proteins, 0.1 % (v Iv) polyoxyethylene sorbitan 
mono laureate (TWEEN-20, Bio Rad, Richmond, CAl, and 2% (v/v) each 
normal sheep (Serotec Ltd., Kidlington, UK) and human AB serum (Im-
muno AG, Vienna, Austria). All sections were exposed to 10% sheep/2% 
human AB serum for 40 min at room temperature (RT) before staining. 
Slides were washed once in Tris-buffered saline, pH 7.6, and twice . ..in PBS 
between all incubation steps. 
For single stainings, sections were incubated overnight at 4 ' C with un-
conjugated MoAb HECA-452, Leu-Ml, or IOT6, followed by either bio-
tinylated sheep-anti-rat Ig antibody (Amersham) or biotinylated sheep-
anti-mouse Ig F(ab'), fragments (Amersham) for 1 hat RT. Detection of 
antibody binding was achieved with peroxidase-conjugated StreptABCom-
plex (Dako A/S, Glostrup, Denmark) and 3-amino-9-ethyl carbazole 
(Sigma) in acetate-buffer (PH 5.0) . Sections were counterstained with 
HARRIS' hematoxylin (Merck) and finally cover-slipped with a mixture of 
PBS/glycerol and Mowiol (Hoechst, Hoechst, Germany) . 
Double stainings were performed by incubating the cryostat sections 
overnight at 4'C in staining-buffer containing MoAb HECA-452. Anti-
body binding was detected by consecutive incubations with biotinylated 
sheep-anti-rat Ig antibody (Amersham) and Streptavidin Texas Red (SA-
TR; Amersham), each for 1 hat RT. For counterstaining, sections were then 
overlaid with MoAb IOT6, the binding of which was visualized by consecu-
tive incubations with fluorescein-isothiocyanate (FITC) -labeled rabbit-
anti-mouse Ig F(ab'), fragments (Dako) diluted in staining buffer (see above) 
containing 2% (v Iv) rat serum and FITC-labeled swine - anti-rabbit Ig anti-
body (Dako) diluted in staining-buffer containing 2% (v Iv) rat serum and 
2% (v Iv) pig serum. Epidermal sheets were labeled with MoAb HECA-
452/SA-TR as described above and counterstained with OKT6-FITC for 
1 hat RT. After final washes in PBS, sheets were mounted dermal side up on 
glass slides and cover slipped with a mixture of PBS/glycerol and Mowiol 
(Hoechst) . In additional experiments, sections were incubated overnight at 
4'C with anti-CD3 MoAb UCHTI (Dako) and antibody binding was de-
tected by consecutive incubations with biotinylated sheep-anti-mouse Ig 
F(ab'),fragments (Amersham) and SA-TR, each for 1 hatRT. Sections were 
then counterstained with OKT6-FITC for another 1 hat RT. 
Cross reactivity between antibodies or unspecific binding via Fc-receptors 
was excluded by using appropriate species/isorype-matched controls (see 
Table I) . Stained sections and sheets were evaluated with a Nikon Epi-F3 
(Nikon, Tokyo, Japan) or a Leitz Diaplan (Leitz, Wetzlar, Germany) epi-
fluorescence microscope equipped with the appropriate excitation and em-
mission filters for FITC and Texas Red illumination. Staining patterns 
observed were documented with an automatic exposure system, using 
Ektachrome P800/ 1600 (Kodak, Rochester, UK) or ILFORD FP4 Plus 
(ILFORD Limited, Mobberley, UK) films . 
Neuraminidase Digestion of Skin Sections Neuraminidase digestion 
of cryostat sections was performed for 30 min at 37'C using 40 mU/m1 
neuraminidase of Vibrio clJOlerae (Behring, Marburg, Germany) in PBS con-
taining 4 mM CaCl2 and 1% (w/v) bovine serum albumin (Sigma). Mock 
digestion was performed in digestion buffer without neuraminidase. After 
washing in PBS, sections were subjected to HECA-452 or anti-CD 15 single 
stainings as described above. 
Enutneration ofEpidertnal and Dertnal Cell Populations To deter-
mine the percentage of HECA-452+ LC, cryostat sections were subjected 
to HECA-452/IOT6 immunofluorescence double-labeling (see above). 
HECA-452+ /CDla+ and HECA-452-/CDla+ epidermal cells were then 
enumerated at 400X magnification, whereby only cells with a clearly visible 
cell body were counted. 160-1100 CDla+ cells were evaluated on three or 
more non-serial sections of the biopsy and the percentage of HECA-452+ 
cells was calculated from the total number of CDla+ cells. To deter-
mine absolute numbers of CDla+ epidermal and dermal cells, peroxi-
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Table II. Quantification of CDla+ Epidermal Cells Expressing HECA-452-Reactive Molecules 
Percentage of CDla+ Epidermal LC Expressing 
HECA-452-Reactive Molecules as Evaluated Estimated Percentage of Suprabasally Located, 
by Immunofluorescence Double-Labeling Dendritic Cells Reactive with MoAb HECA-452' 
Number of % HECA-452+ Number of 
Sample Specimens of CD1a+ Cells Specimens > 90% 50-90% 20- 50% <20% 0% 
Normal skin 3 20 ± 18' 1 0 0 0 1 0 
Atopic eczema 3 72 ± 12 3 0 3 0 0 0 
Contact eczema 1 73 2 1 1 0 0 0 
Pseudo lymphoma 1 83 5 0 1 3 1 0 
psoriasis 3 1 0 2 0 0 
Parapsoriasis 4 0 3 1 0 0 
Viral exanthem 1 53 
CD30+ secondary LCALb 1 86 
CTCL (Mf-type)' 2 73 ± 32 8 0 6 0 
Seborrheic keratosisd 1 4 
• Serial sections were stained with either HECA-452 or OKT6 MoAbs. The percentage of HECA-452+ LC was estimated by the comparison of the number of OKT6+ and 
HECA-452+ suprabasally located dendritic cells. Only data from specimens not evaluated by immunofluorescence double-label ing are included in this part of the table . 
• CD30+ secondary large cell anaplastic lymphoma. HECA-452+ and COla+ cells were counted within the epidermis above the barely epidermotropic neoplastic infiltrate. 
, HECA-452+ and COla+ cells were counted in the lesional epidennis partly infiltrated by neoplastic T cells. 
J HECA-452+ and COla+ cells were counted within the epidermal cords of the lesion, as well as, in the perilesional epidermis. In both instances 4% of the COla+ cells coexpressed 
HECA-452-antigens. 
, Results are means ± SO. 
clase -anti-CD 1a - stained sections were used. The numbers of positive cells 
per linear millimeter basement membrane as well as per square millimeter 
were evaluated in the epidermis and the papillary dermis using a semi-auto-
matic image analysis system (Vidas, Kontron Elektronik GmbH, Eching, 
Germany). 
Flo-w-Cytometric Analysis of Epidermal Cells Epidermal cells were 
prepared for flow-cytometric analysis by washing in azide containing buffer 
(PBS/l % fetal bovine serum/O.l % sodiumazide/0.5 rnMethylene diamine-
tetraacetic acid) followed by incubation with normal sheep serum (5%, v Iv) 
and further washes in azide containing buffer. 1 X 106 cells/lOO III were 
reacted with first-step antibodies (HECA-452, CSLEX 1, or control IgM) for 
30 min on ice and washed once in azide containing buffer. Antibody-binding 
was visualized by incubation with either biotinylated sheep -anti-rat Ig anti-
body (Amersham) or biotinylated sheep-anti-mouse Ig F(ab'), fragments 
(Amersham) for 20 min on ice followed by Streptavidin Phycoerythrin 
(SA-PE; Becton Dickinson, San Jose, CAl. Cells were then counterstained 
for 20 min with either MoAb OKT6-FITC, HLe-l-FITC, or species/iso-
rype-matched FITC-Iabeled control MoAb. After two washes fluorescence 
was measured in a FACScan (Becton Dickinson). Dead cells were identified 
by 7-amino-actinomycin D (7-AAD; Sigma) uptake and electronic gates 
were first set to acquire 10,000 living cells and then set to acquire only 
CD1a+ living cells. 
RESULTS 
HECA-452-reactive Cells in Normal Skin Exposure of cry-
ostat sections of normal human skin to MoAb HECA-452 revealed 
the presence of stained cells scattered throughout the epidermis and 
dermis. Within the dermis, the majority of labeled cells were lo-
cated in the vicinity of vessels, displayed a round shape, and, thus, 
presumably represent T lymphocytes [7,8,16] . As previously re-
ported [16-18J, dermal endothelial cells were essentially non-reac-
tive with MoAb HECA-452. Epidermal HECA-452+ cells con-
sisted of i) a few round cells scattered throughout the basal layer 
(again probably representing T cells [8,16]) and ii) suprabasally lo-
cated dendritic cells (data not shown). To see whether the latter cells 
are LC, we subjected cryostat sections and sheets of normal skin 
to an immunofluorescence double-labeling protocol using MoAb 
HECA-452 and anti-CDla MoAb IOT6. Results obtained revealed 
that 5 to 40% (20 ± 18%, mean ± SD; Table II) of CDla+ epider-
mal cells specifically bound MoAb HECA-452. Although the ma-
jority of these cells exhibited only a weak HECA-452 reactivity, a 
few brightly stained cells were also detected (Fig 1). The intensity of 
the HECA-452 staining did not correlate with the level of CDla 
expression, because LC that stained weakly with anti-CDla MoAb 
sometimes expressed high levels of HECA-452-antigens and vice 
versa. As opposed to the results obtained on tissue preparations, we 
found that most, if not all, CDla+ cells reacted with the MoAb 
HECA-452 when single-cell suspensions of normal epidermis were 
stained and analyzed by flow cytometry (Fig 2). To verify that the 
epidermal HECA-452+ /CD1a+ cells are LC and do not represent 
HECA-452+ /CDla+ T cells, we performed CDla/CD3 double-
labeling of cryostat sections. In keeping with the literature [1 ,19], 
we never detected CDla+ cells expressing CD3-determinants (data 
not shown), indicating that the epidermal HECA-452+ /CDla+ 
cells indeed represent LC. Keratinocytes did not stain with MoAb 
HECA-452 on cryostat sections, on epidermal sheets, or in single-
cell suspensions (Figs 1 and 2). 
HECA-452-Reactive Cells in Diseased Skin In view of re-
ports of increased numbers of HECA-452+ cells in inflamed skin 
[18]. we asked whether this increase could be, at least partially, due 
to an increase in the number of HECA-452+ LC. When we ana-
lyzed skin sections from various inflammatory and neoplastic lym-
phocytic skin disorders for HECA-452-antigen expression, we 
noted considerably larger numbers of HECA-452+ cells in both 
dermis and epidermis of diseased skin as compared to normal skin. 
Double-staining with anti-CDla MoAb revealed that i) approxi-
mately 50% of the HECA-452+ cells in the dermis belong to the 
LC-lineage and ii) that 50% to 80% of all CDla+ dermal cells 
exhibited a strong labeling with the MoAb HECA-452 (Fig 3). The 
increase in absolute numbers of dermal HECA-452+ cells was 
therefore not only due to an elevation in HECA-452+ /CD la- cells 
(Fig 3), which according to the literature are likely T cells [8,16] and 
monocytic cells [16,18], but was also due to an increase in the abso-
lute numbers of CDla+ dermal cells (Table III). In contrast, the 
marked increase in HECA-452-reactive epidermal cells was not 
accompanied by elevated numbers of CD1a+ cells (Table III), was 
not due to a substantial increase in HECA-452+ non-LC (except in 
MF, data not shown), but rather a consequence of enhanced HECA-
452-antigen expression by CD1a+ dendritic cells (Fig 3). Enumer-
ation ofHECA-452+ /CDla+ and HECA-452-/CDla+ cells in the 
epidermis of the various inflammatory and neoplastic lymphocytic 
dermatoses studied revealed that 53-95% (71 ± 17%, mean ± SD) 
of the CDla+ cells expressed HECA-452 - reactive epitopes (Table 
II , left columns). To confirm that the enhanced expression ofHECA-
452-reactive moieties on CDla+ cells is representative of the ex-
amined disease entities, we subjected a larger panel of sections ob-
tained from additional patients to HECA-452 single-labeling. 
Results obtained showed again that, compared to the situation in the 
skin of normal healthy volunteers, the lesional epidermis from pa-
tients with pseudolymphoma, atopic and contact eczema, psoriasis, 
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Figure 1. Demonstration ofHECA-452 reactivity of epidermal Langerhans cell of normal skin. Cryostat sections were reacted with MoAb HECA-452/SA-
TR and counterstained with anti-CDla (IOT6)/FITC. Single photographic exposures with the appropriate filters show HECA-452+ cells in red (A,B) and 
COla+ cells in green (a,b). In some epidermal areas most of the COla+ cells react with the HECA-452 MoAb (A,a) , whereas in other areas only few COla+ 
cells coexpressed the HECA-452-antigen (B,b). While daiS, dermal epidermaljuction. Bar, 30 Jim. 
I?arapsoriasis, viral exanthem, and cutaneous T-cell lymphoma 
(CTCL) contained substantially elevated numbers of HECA-452+ 
dendritic cells {Table II, right columns}. In contrast, in seborrheic 
keratosis, a proliferative disorder of keratinocytes not accompanied 
by T-cell infiltration, the percentage of HECA-452+ e,ridermal 
CDla+ cells was comparable to that seen in normal skin (Table II , 
left column) . To exclude the possibility that changes in the cytokine 
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profile oflesional skin compared to normal skin could induce CDla 
expression on skin T cells, we double labeled sections of the same 
specimens as used for the evaluation ofHECA-452 expression with 
anti-CDla and anti-CD3 MoAbs. Because these MoAbs reacted 
with mutually exclusive cell ,Populations {data not shown}, we con-
clude that the HECA-452+ /CDla+ cells in the lesional epidermis 
represent LC. 
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Figure 2. Flow-cytometric analysis ofHECA-452-antigen expre:lsion on epidermal cells. Cells of normal epidermis were labeled with MoAb HECA-452 
(A,B) or control IgM (C) followed by appropriate second step MoAb/SA-PE and counterstained with HLe-l-FITC (anti-CD45; A) or OKT6-FITC 
(anti-COla; B,C). Ten thousand cel ls were recorded in A, demonstrating that nearly all C045+ cells express HECA-452 antigens (lipper right), whereas 
keratinocytes are essentially negative (lower left). Six thousand COla+ cells were recorded in Band C, demonstrating that more than 90% of COla+ celIs react 
with the MoAb HECA-452 (B) and not with the control rat IgM (C). Data of one of four similar experiments are shown. 
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Figure 3. Demonstration of HECA-452+ /CD~a+ cells in diseased skin. Skin sect.ions o.f an atopic dermatitis (A) and a pseudolymphoma (B) lesion were 
reacted with HECA-452/SA-TR and IOT6 (antl-CD1a)/FITC. Most of the dendntlc epidermal cells In these double photographic exposures appear yellow 
indicating that they bind MoAbs IOT6 (green) and HECA-452 (red). These yellow cells therefore represent HECA-452-antigen expressing LC. Bar, 
100j.lm. 
serologic Characterization of the HECA-452-Reactive 
Molecule on LC The reactivity of LC with MoAb HECA-452 
could be indicative of the presence of sLe>, sLex or related molecules 
on these cells. To address this question we performed a series of 
experiments the results of which strongly imply that the HECA-
452-reactive epitope on LC is sLex. First, epidermal single-cell 
suspensions were double-labeled with anti-sLex MoAb CSLEX1 
and anti-CDla MoAb OKT6. All CD1a+ cells reacted with the 
CSLEXl MoAb and the staining pattern observed was similar to 
that obtained with MoAb HECA-452 (Fig 4) . Second, skin sections 
were treated with neuraminidase or control buffer and then either 
stained with MoAb HECA-452 or anti-CD15. Whereas epidermal 
cells in the mock-digested samples reacted with MoAb HECA-452, 
but not with anti-CD15 MoAb Leu-M1, neuraminidase digestion 
of the sections led to the loss of HECA-452 reactivity and to the 
gain of anti-C?15 reactivity (Fig 5). These data. show that the 
epitope recogmzed by the MoAb HECA-452 on epidermal LC and 
T cells is a sialylated form of LeX. In concordance with the absence 
of HECA-452-reactivity on keratinocytes, we could not detect 
binding of MoAb CSLEX1 on this epidermal cell population (Fig 
4), and keratinocytes in the neuraminidase digested sample did not 
label with MoAb Leu-M1 (Fig 5) . 
DISCUSSION 
The rat MoAb HECA-452 has been described to recognize carbo-
hydrate moieties on skin-prone memory T cells [7]. We have now 
detected similar antigens on human epidermal LC. Immunolabe-
ling of cyrostat sections and epidermal sheets of normal skin re-
vealed the presence of HECA-452 antigens on some suprabasally 
located dendritic CDla+ cells and sensitive flow-cytometric studies 
of single cell suspensions indicated that almost aU CD1a+ epidermal 
cells express the HECA-452-reactive epitope. In lesional skin of 
inflammatory as well as neoplastic lymphocytic skin diseases we 
found a marked upregulation of HECA-452 expression compared 
to normal skin, with up to 95% of the CD1a+ cells showing positive 
immunolabeling on cryostat sections. Concerning the nature of the 
HECA-452-reactive epitope on LC, we have shown that neura-
minidase treatment of cryostat sections leads to the loss of the 
HECA-452 reactivity and unmasking of CD15 molecules and that 
CD1a+ epidermal cells react with the anti-sLex MoAb CSLEX1. 
At first glance, the detection ofHECA-452- reactive epitopes on 
LC may be surprising because Bos et af [16] recently reported 
HECA-452 MoAb binding to T-cell and macrophage subpopula-
tions of normal skin, but absence ofHECA-452 immunolabeling of 
epidermal CDla+ cells. In addition, Jalkanen et af [18] reported 
enhanced numbers of HECA-452+ and CD1a+ dendritic cells in 
diseased versus normal skin, but stated that the populations recog-
nized by MoAbs HECA-452 and anti-CDla were not identical. We 
would presume that the sensitivity of the staining system used may 
account for the discrepancies between these observations and our 
finding. In this context, it should be emphasized that i) the HECA-
452 labeling we detected on approximately 20% of CD1a+ cells in 
cryostat sections of normal skin was generally rather dull and ii) that 
uniform HECA-452 labeling of LC was only revealed by flow-
cytometric analysis of epidermal single cell suspensions. In principle 
this difference could be due to i) the higher sensitivity of flow-cyto-
Table III. Number of CD1a+ Epidermal and Dermal Cells in Normal and Diseased Skin 
Number of CD1a+ Number of CDla+ Number of CD1a+ Number of CD1a+ 
Number of Epidermal Cells/mm Epidermal Cel ls/mm2 Dermal Cells/ mm Dermal Cells/ mm2 
Sample' Specimens Basement Membrane Epidermal Area Basement Membrane Dermal Area 
Normal skin 3 27 ±2' 583 ± 127 5 ± 1 47 ± 10 
Atopic eczema 4 32±9 307 ± 108 28 ± 15 253 ± 49 
Contact eczema 3 37 ± 31 460 ± 441 63 ± 65 512 ± 385 
Pseudolymphoma 3 33 ± 18 518 ± 318 14 ± 11 116 ± 85 
Parapsoriasis 3 46±8 744 ± 293 52 ± 17 583 ± 180 
Viral exanthem 1 45 727 17 205 
CD30+ secondary LCALb 1 27 376 9 84 
CTCL (ME type) 4 52 ± 19 567 ± 200 43 ± 24 385 ± 183 
• With the exception of contact eczema and parapsoriasis, data were obtained from sections cut from the same biopsies as used for the determination of the percentage of 
HECA-452+ LC (Table II). In the case of contact eczema and parapsoriasis two and three biopsies, respectively, were obtained from patients other than those used in T able U. 
b CD30+ secondary large cell anaplastic lymphoma. 
, Results are means ± SD. 
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Figure 4. Flow-cytometric analysis of sLeX expression on epidermal cells. Cells of normal epidermis were labeled with controllgM (A), anti-sLex MoAb 
CSLEXl (B), or MoAb HECA-452 (e) followed by appropriare second-step MoAb/SA-PE and counterstained with OKT6-FITC. CD1a+ cells bound MoAb 
CSLEX1 (B) in a similar fashion as they bound MoAb HECA-452 (C) . Keratinocytes (cells in the lower left quadrant) did not react with these MoAbs. 
Contour graphs of 20,000 cells of one of three similar experiments are shown. 
metric analysis compared to fluorescence microscopy, ii) an un-
masking of the reactive epitope by the enzyme treatment used to 
prepare the single cell suspension, and/or iii) an upregulation of this 
antigen during cell preparation~ [20]. However, because treatment 
of cryostat sections from normal skin with trypsin prior to staining 
did not lead to enhanced reactivity of MoAb HECA-452 with LC 
and because there was no significant variation in HECA-452 reac-
tivity on LC in epidermal sheets prepared with either trypsin, dis-
pase, or NH4SCN (data not shown), unmasking of HECA-452-
reactive epitopes by trypsin does not seem to be the reason for the 
detection of higher percentages of HECA-452+ cells upon flow 
cytometry compared to in sil/j immunohistochemistry. This con-
clusion is further supported by the observation that an epidermal 
single cell suspension prepared with dispase and ethylene diamine-
tetraacetic acid showed a similar staining pattern as the trypsin-
treated sample of the same specimen (data not shown). The third 
possibility, namely, upregulation of the HECA-452 antigen during 
cell preparation. also seems to be a rather unlikely explanation. 
because ex villo culture of whole skin specimens up to 72 h did not 
result in increased HECA-452 binding to LC (data not shown). Due 
to theoretical considerations (such as the higher amount of antigen 
present on single cells compared to sectioned cells and the higher 
sensitivity of photomultipliers in the flow cytometer compared to 
the investigators eyes examining tissue specimens by fluorescence 
microscopy), we believe that the main reason for the discrepancy 
between the in sitll and the flow-cytometry results is the different 
sensitivity of the two readout systems used. 
The structure recognized by the MoAb HECA-452 has been re-
ported to be serologically identical to sLex on neutrophils [11] but to 
differ from sLeX on established memory/effector T cells [7,10,11]. 
Although the molecular configuration detected by HECA-452 on 
monocytes [8], dendritic cells [21], and high endothelial venules 
[17,22] has not been studied in detail. it seems to involve sLex 
beca,use these cells react with the sLex-specific MoAb CSLEX1 
[23 - 26]. To define the molecular configuration of the HECA-
452-reactive epitope on LC we performed two series of experi-
ments. First, double-labeling of epidermal single cell suspensions 
with CSLEX1 and anti-COla MoAbs revealed that all LC express 
" 
~ Mommaas AM, Mulder AA, Vermeer BJ, Koning F: Human Langcr-
hans cells in situ do not constitutively display high cell surface expression of 
HLA-class 1I molecules (abstr.).] Illvest Dermaloi100:436, 1993. 
sLex. This result confirms a recent publication showing that C01a+ 
cells of buccal muCOsa and normal skin label with the anti-sLeX 
MoAb FH6 [27]. In further experiments, we found that treatment of 
skin sections with neuraminidase leads to the loss of HECA-452 
binding and to the unmasking of C01S (LeX) [19]. similar to what 
has been reported for T cells [11 J. These experiments show that 
binding ofHECA-452 is dependent on the expression of LeX carbo-
hydrates decorated with sialic acid. Although these data strongly 
suggest that the HECA-452-reactive structure on LC is sLex, the 
expression of other HECA-452 - reactive oligosaccharides cannot 
be excluded. In addition to HECA-452 recognizing different carbo-
hydrate molecules on different cells. the protein backbone to which 
the carbohydrates are attached also differs between various leuko-
cyte subsets [8]. Proteinbiochemical studies would be needed to 
fully characterize the HECA-452 -reactive antigens on LC. 
Although Symington et al [28] recently reported that trypsin-
treated keratinocytes react with an anti-sLex MoAb, we could not 
detect binding of either HECA-452 or CSLEX1 to trypsin-treated 
keratinocytes. Because Symington et al [28] used different MoAbs, 
one explanation for the contradictory result might be that the 
MoAbs employed by us do not bind to keratinocytes because of 
lower affinity and/or steric hindrance. 
How is the expression of the HECA-452-reactive molecule on 
LC regulated? It is known that T cells acquire CLA expression 
during the naive to memory cell transition in skin-associated pe-
ripherallymph nodes [7] and that CLA expression can be induced 
in vitro by mitogen stimulation ofT cells in combination with inter-
leukin-6 or transforming growth factor-fJ [7] . In analogy one might 
presume that the HECA-452 - reactive structure on LC may also be 
induced by the presence of antigen and cytokines. Compatible with 
this assumption are our data that LC residing in the epidermis of 
lesional skin from inflammatory or neoplastic lymphocytic disor-
ders show a markedly enhanced expression ofHECA-452-reactive 
molecules. Both the percentage of LC expressing detectable levels 
of HECA-452- reactive molecules (71 ± 17% versus 20 ± 18%, 
P < 0.001) and the intensity of staining with this MoAb on a single 
celllevcl were increased in diseased versus normal skin. In contrast, 
in seborrheic keratosis. a hyperproliferative disorder of keratino-
cytes not accompanied by T-cell infiltration, only small numbers of 
HECA-452+ LC were seen. Thus, it is possible that cytokines re-
leased from the infiltrating/neoplastic T cells may induce the ex-
pression of HECA-452-reactive antigens on resident epidermal 
LC. On the other hand, it is equally conceivable that LC precursors 
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Figure 5. HECA-4S2-reactive epitopes on. LC have a COtS carbohydrate backbon~. Serial cryostat skin sections were treated with buffer (A,C) or 
neuraminidase (B,D) and then reacted with either MoAb HECA-4S2 (A ,B) or with ann-COtS MoAb Leu-Mt (C,D). Cells 111 the mock digested samples 
were HECA-4S2 - reactive (A) but did not stain wi th anti-C01S MoAb (C) . After neuraminidase treatment, cells had fost reactivity with MoAb HECA-4S2 
(B) but gained reactivity with MoAb Leu-Mt (D). Bar, 30 11m. 
enter the skin in a HECA-452+ state. Once establishing residence in 
the epidermis, the cytokine level they encounter determines the 
degree to which HECA-452-antigen expression is maintained. 
CONCLUSION 
At the moment, it is unclear which, if either, of these concepts is 
valid. The assumption that the functional significance of HECA-
452 - antigen expression by a given cell is to allow its binding to 
E-selectin provides us with a logical argument favoring the latter 
hypothesis. First, there is no evidence for a role of HECA-452-
antigen expression on resident LC, especially as keratinocytes do 
not express E-selectin [14,29] and adhesion of LC to keratinocytes 
has been shown to be mediated via E-cadherins [30] . Second, the 
possibility that resident LC upregulate HECA-452-antigen ex-
pression when they leave the epidermis to gain access to the lym-
phatics [31] is unlikely, because i) we have not seen E-selectin 
expression on vascular structures consistent with lymphatics 
(L. Picker, unpublished observation) and ii) we are not aware of data 
indicating that receptor-ligand interactions playa role in lympho-
cyte recruitment into lymphatic vessels. Conversely, there is cir-
cumstantial evidence supporting the hypothesis that LC precursors 
express HECA-452 antigens, which might enable these precursors 
to bind to the dermal microvasculature and, thus, faci litate their 
extravasation into the skin. Our observation of markedly enhanced 
numbers of HECA-452+ /CD1a+ cells in the dermis of most derma-
toses studied may be taken as an indication of an increased immigra-
tion of LC-precursors into lesional skin. The upregulation of E-
selectin expression by the dermal microvasculature in inflammatory 
skin [14] and in neoplastic lymphocytic disorders [32] may provide 
the necessary basis for this process. After LC (precursors) reach 
the epidermis and take residence between the keratinocytes their 
HECA-452-antigen expression would then gradually decrease ei-
ther due to a lack of appropriate stimuli or due to active downregu-
lation. This might explain our finding that in normal skin, where 
recruitment of LC would be expected to be at relatively low levels, 
most LC are HECA-452- /du ll . The observation that developing 
monocytes upregulate HECA-452 reactivity in the bone marrow, 
maintain high levels in the blood, and rapidly lose expression of 
these determinants during differentiation into tissue macrophages 
(both il1l1ilro and ill lIillO, L. Picker, unpublished), is in keeping with 
this concept. The identification of cells in the peripheral blood that 
react with HECA-452 or CSLEX1 and do not express either T-cell 
or neutrophil markers may verify this hypothesis and perhaps even 
lead to the discovery of the still elusive LC-precursor. 
Tlais work was supported by Crallt P 8536-Med fro III tlae A llstria ll Sciellce fOil II da-
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